Diphenyl diselenide and analogs are substrates of cerebral rat thioredoxin reductase: A pathway for their neuroprotective effects

Neuroscience Letters

Volumn 503, Issue 1, 2011, Pages 1-5

  De Freitas, Andressa Sausen ^a   Rocha, João Batista Teixeira ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Diphenyl diselenide; Ebselen; Selenium compounds; Thioredoxin reductase (TrxR)

Indexed keywords

2,4,6,2',4',6' HEXAMETHYLDIPHENYL DISELENIDE; 4,4' BISCHLORODIPHENYL DISELENIDE; 4,4' BISMETHOXYDIPHENYL DISELENIDE; 4,4' BISTRIFLUOROMETHYLDIPHENYL DISELENIDE; 4.4' BISCARBOXY DIPHENYL DISELENIDE; DIPHENYL DISELENIDE; EBSELEN; GLUTATHIONE PEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; LIVER; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 84984550859     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.07.050     Document Type: Article

References (26)

1. Arnér E.S.J. Focus on mammalian thioredoxin reductases - important selenoproteins with versatile functions. Biochim. Biophys. Acta 2009, 1790:495-526.
2. Barbosa N.B.V., Rocha J.B.T., Wondracek D.C., Perottoni J., Zeni G., Nogueira C.W. Diphenyl diselenide reduces temporarily hyperglycemia: possible relationship with oxidative stress. Chem. Biol. Interact. 2006, 163:230-238.
3. Barbosa N.B.V., Rocha J.B.T., Soares J.C.M., Wondracek D.C., Gonçalves J.F., Schetinger M.R.C., Nogueira C.W. Dietary diphenyl diselenide reduces the STZ-induced toxicity. Food Chem. Toxicol. 2008, 46:186-194.
4. Celi P. Biomarkers of oxidative stress in ruminant medicine. Immunopharmacol. Immunotoxicol. 2011, 33:233-240.
5. Dawson D.A., Masayasu H., Graham D.I., Macrae I.M. The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci. Lett. 1995, 185:65-69.
6. de Freitas A.S., Prestes A.S., Wagner C., Sudati J.H., Alves D., Porciúncula L.O., Kade I.J., Rocha J.B.T. Reduction of diphenyl diselenide and analogs by mammalian thioredoxin reductase is independent of their gluthathione peroxidase-like activity: a possible novel pathway for their antioxidant activity. Molecules 2010, 15:7699-7714.
7. Erbil G., Ozbal S., Sonmez U., Perkcetin C., Tugyan K., Bagriyanik A., Ozogul C. Neuroprotective effects of selenium and ginkgo biloba extract (EGb761) against ischemia and reperfusion injury in rat brain. Neurosciences 2008, 13:233-238.
8. M. Farina, M. Aschner, J.B.T. Rocha, Oxidative stress in MeHg-induced neurotoxicity, Toxicol. Appl. Pharmacol., doi:10.1016/j.taap%202011.05.001.
9. Flemer S. Selenol protecting groups in organic chemistry: special emphasis on selenocysteine Se-protection in solid phase peptide synthesis. Molecules 2011, 16:3232-3251.
10. Gille G., Reichmann H. Iron-dependet functions of mitochondria-relation to neurodegereration. J. Neural Transm. 2011, 118:349-359.
11. Hill K.E., McCollum G.W., Boeglin M.E., Burk R.F., Thioredoxin Reductase activity is decreased by selenium deficiency. Biochem. Biophys. Res. Commun. 1997, 234:293-295.
12. Jomova K., Jenisova Z., Feszterova M., Baros S., Liska J., Hudecova D., Rhodes C.J., Valko M., Arsenic Toxicity, oxidative stress and human disease. J. Appl. Toxicol. 2011, 31:95-107.
13. Lu J., Holmgren A. Selenoproteins. J. Biol. Chem. 2009, 284:723-727.
14. Luchese C., Nogueira C.W. Diphenyl diselenide in its selenol form has dehydroascorbate reductase and glutathione-S-transferase-like activity dependent on the glutathione content. J. Pharm. Pharmacol. 2010, 62:1146-1151.
15. Maruszak A., Zekanowski C. Mitochondrial dysfunction and Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:320-330.
16. Mugesh G., Dumont W.W., Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem. Rev. 2001, 101:2125-2179.
17. Nogueira C.W., Zeni G., Rocha J.B. Organoselenium and organotellurium compounds: pharmacology and toxicology. Chem. Rev. 2004, 104:6255-6286.
18. Nogueira C.W., Rocha J.B.T., Diphenyl Diselenide a janus-faced molecule. J. Braz. Chem. Soc. 2010, 21:2055-2071.
19. C.W. Nogueira, J.B.T. Rocha, Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds, Arch. Toxicol., doi:10.1007/s00204-011-0720-3.
20. Ozbal S., Erbil G., Kocdor H., Tugyan K., Pekcetin C., Ozogul C. The effects of selenium against cerebral ischemia-reperfusion injury in rats. Neurosci. Lett. 2008, 483:265-269.
21. Rackham O., Shearwood A.M.J., Thyer R., McNamara E., Davies S.M.K., Callus B.A., Vizuete A.M., Berners-Price S.J., Cheng Q., Arner E.S.J., Filipovska A. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for developments of specific inhibitors. Free Radic. Biol. Med. 2011, 50:689-699.
22. Saito I., Asano T., Takakura K., Abe H., Yoshimoto T., Kikichi H., Ohta T., Ishibashi S. Neuroprotective effect of an antioxidant, ebselen, delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery 1998, 42:269-277.
23. Steinbrenner H., Sies H. Protection against reactive oxygen species by selenoproteins. Biochim. Biophys. Acta 2009, 1790:1478-1485.
24. Valko M., Leibfritz D., Moncol J., Cronin M.T.D., Mazul M., Telser J. Free radical and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
25. Zhao R., Holmgren A. A novel antioxidant mechanism of ebselen involving ebselen diselenide, a substrate of mammalian thioredoxin and thioredoxin reductase. J. Biol. Chem. 2002, 277:39456-39462.
26. Zhao R., Masayasu H., Holmgren A., Ebselen A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:8579-8584.